Jason Smith (Chief Technology Officer at Within3)2025-10-24T13:17:47
Within3’s Jason Smith explores how artificial intelligence is breathing new life into next-generation launch situation rooms; delivering actionable insights for pharmaceutical companies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2023-04-12T15:15:18
Sponsored by Cellistic
2026-06-04T07:05:00
Author Graham Craig
2025-06-02T10:00:00
Contributor Professor Stefan Trapp, Drug Target Review
2023-03-20T13:41:33
Sponsored by Bio-Techne
Site powered by Webvision Cloud